Tocilizumab for Treatment of Steroid Refractory Acute Graft-versus-Host Disease

NCT01475162 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
TERMINATED
Status
14
Enrollment
OTHER
Sponsor class

Stopped The DSMB felt the risks of the study now outweighed the potential benefits.

Conditions

Interventions

Sponsor

Medical College of Wisconsin